Latest Investment Valuation News

CONNEQT Health has disclosed significant revisions to its 2025 financial results, highlighting increased losses driven by a larger-than-expected fair value write-down on its inHealth investment and a heightened inventory provision.

Hydrix Limited delays its FY25 financial statements due to a pending independent valuation of its Wavewise Analytics shareholding, triggering an automatic trading suspension from 1 October 2025.

Rewardle Holdings reported a modest revenue increase for FY25 but saw its loss more than double, driven by investments in AI-powered MedTech associate CloudHolter and expanded platform initiatives.

Duxton Farms proposes a scheme of arrangement to acquire all preference shares of Duxton Orchards, offering scrip with optional cash consideration. An independent expert values the transaction as fair and reasonable, highlighting the strategic benefits of a larger, diversified agricultural platform.

The 2025 annual report for SPDR Core Equity ETFs confirms compliance with accounting standards and provides detailed unitholder data, underscoring the funds' robust governance and market position.

JPMorgan Asset Management has announced the final cash distributions for February 2025 across several of its active ETFs, providing investors with key dates and reinvestment options.